GlassScriptPhysician profile
Bart E Muhs
NPI 1811928492
$65,876.53
in general payments reported to CMS, 2019-2025
29 companies · $22K in 2025
The $22K reported for 2025 was more than what 95% of Vascular Surgery providers received nationally (typical 2025 total: $927).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,755 · 2020: $7,790 · 2021: $613 · 2022: $1,880 · 2023: $12K · 2024: $20K · 2025: $22K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Long Term Medical Supply Or Device Loan: $37K · Food and Beverage: $11K · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $4,960 · Travel and Lodging: $798.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Long Term Medical Supply Or Device Loan | $36,583.34 |
| Food and Beverage | $11,496.94 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $4,960.00 |
| Travel and Lodging | $797.55 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Angiodynamics, INC. | $36,767.97 | 2021-2025 | Auryon Laser System 100-120 Vac, Auryon Laser System 100-120 Vac |
| Saranas, INC. | $7,807.26 | 2020-2023 | |
| Cook Incorporated | $4,960.00 | 2024 | Zenith Spiral-Z, Zenith |
| Endologix LLC | $4,293.05 | 2023-2025 | Alto Abdominal Stent Graft System, Torus Stent Graft System, Endocross Device |
| Medtronic, INC. | $4,223.67 | 2022-2025 | Endurant Iis, Ellipsys Vascular Access System, Heli-Fx Endoanchor System |
| Boston Scientific Corporation | $2,797.85 | 2019-2025 | Opticross 35, Eluvia, Jetstream Sc |
| Cook Medical LLC | $1,445.75 | 2019-2025 | Zenith Spiral-Z, Cook, Zenith |
| Janssen Pharmaceuticals, INC | $1,245.80 | 2019-2024 | Xarelto |
| E.R. Squibb & Sons, L.L.C. | $345.51 | 2020-2025 | Eliquis |
| Philips North America LLC | $284.24 | 2019-2022 | |
| Mimedx Group, INC. | $205.16 | 2024 | |
| Smith+Nephew, INC. | $204.99 | 2022-2024 | Grafix Pl, Stravix, Collagenase Santyl |
| Reflow Medical INC | $180.69 | 2024-2025 | |
| Silk Road Medical, INC. | $180.06 | 2019-2020 | |
| Integra Lifesciences Corporation | $117.42 | 2023-2024 | Integra, Integra Dermal Regeneration Template, Primatrix |
Show all 29 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Contego Medical, INC | $112.37 | 2024 | |
| Medtronic Vascular, INC. | $104.08 | 2019 | |
| Cardiovascular Systems INC. | $89.11 | 2019-2021 | |
| Abbott Laboratories | $85.92 | 2019-2022 | |
| Lemaitre Vascular, INC. | $75.02 | 2019-2023 | Artegraft Vascular Graft |
| Tactile Systems Technology INC | $57.85 | 2022-2025 | Flexitouch Plus, Entre Plus, Nimbl |
| Veryan Medical Incorporated | $52.83 | 2021 | |
| Terumo Medical Corporation | $46.48 | 2022-2024 | Azur Cx Detachable, Metacross Otw, Angio-Seal |
| Cordis US Corp. | $44.85 | 2023-2025 | Radial 360, Outback |
| Siemens Medical Solutions USA, INC. | $40.14 | 2021 | |
| Inari Medical, INC. | $38.13 | 2022 | |
| Bard Peripheral Vascular, INC. | $36.54 | 2019-2020 | |
| Bolton Medical INC | $17.49 | 2023 | Relay Thoracic Stent-Graft With Plus Delivery System |
| Kci USA, INC. | $16.30 | 2023 | Prevena, Activ.A.C. |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Bart Muhs listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.